Psychotropic drugs, eating behaviour and weight gain.
Curr Opin Psychiatry
; 37(5): 331-336, 2024 Sep 01.
Article
en En
| MEDLINE
| ID: mdl-38994802
ABSTRACT
PURPOSE OF REVIEW Psychotropic drug related weight gain is a common side-effect of significant concern to both clinicians and patients. Recent studies and treatment guidelines strongly support taking preventive and early treatment approaches to psychotropic drug-related weight gain (PDWG). Arguably the main pathway that PDWG occurs is via changes in eating behaviour leading to increased caloric intake. RECENT FINDINGS:
Systematic reviews and meta-analyses have provided good data on the nature and prevalence of alterations in eating behaviour with psychotropic treatment including increased hunger, night eating and binge eating. These changes are unsurprisingly more prominent with agents like olanzapine and clozapine that have high propensity to cause weight gain.SUMMARY:
Altered eating behaviour can serve as an earlier measure of the risk of weight gain and can be examined easily in clinical practice. Detecting these changes can enable earlier action in terms of switching treatments and starting pharmacological and nonpharmacological preventive strategies.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Psicotrópicos
/
Aumento de Peso
/
Conducta Alimentaria
Límite:
Humans
Idioma:
En
Revista:
Curr Opin Psychiatry
/
Curr. opin. psychiatr
/
Current opinion in psychiatry
Año:
2024
Tipo del documento:
Article
País de afiliación:
Australia